Paclitaxel-coated devices under close watch by FDA following long-term, follow-up data

Minimally invasive interventions for treating peripheral artery disease (PAD) are growing as they continue to demonstrate better patient outcomes compared to pharmaceutical treatment and open surgery.



  • Peripheral artery disease treatment